As of Aug 29
| -0.07 / -0.46%|
The 4 analysts offering 12-month price forecasts for Vanda Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 20.00 and a low estimate of 15.00. The median estimate represents a +11.40% increase from the last price of 15.26.
The current consensus among 4 polled investment analysts is to Buy stock in Vanda Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.